Alerje

Alerje

Private
Detroit, MichiganHealthcare & Life Scienceshttps://www.alerje.com

Last Round

Grant

Sep 7, 2023

Est. Valuation

$2M

Total Funding Raised

$1.41M

Momentum Score

75 /100

Company Overview

Alerje is a healthcare technology company that offers an emergency medicine and digital oral immunotherapy management platform aimed at enhancing the quality of life for individuals with food allergies.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Patient Engagement, Health IoT, Medical AI

Business Model

B2B

Customer Profile

Subscription SaaS, Government Contracts, Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

food allergy managementOral Immunotherapy supportOIT supportdigital therapeuticsDTxallergy carepatient management softwareallergy clinics softwareremote therapeutic managementRTMHealthTechB2B SaaSpatient engagement platformAI-powered allergy careepinephrine auto-injectorsmartphone integrated auto-injector

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Alerje Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Alerje Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantSep 7, 2023
SeedAug 4, 2023
GrantJul 8, 2021
SeedApr 14, 2021
AcceleratorMar 8, 2019
Grant
Nov 16, 2017

Key People

Founding team and executive leadership

Javier Evelyn

Founder & CEO, Principal Investigator (Phase 1 NSF SBIR Grant)

Founding Team

Alerje Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 18, 2026

    Monthly visitors grew 109% MoM, reaching 1.4K.

Alerje Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Alerje Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Alerje's valuation, stock price, and market status.

Firmographic Details

HeadquartersDetroit, Michigan
Employee Range8
Year Founded2016
Last FundingSep 7, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.